Advances in the preclinical characterization of the antimicrobial peptide as-48

HIGHLIGHTS

• who: ufeffRubu00e9nufeff ufeffCebriu00e1nufeff and colleagues from the University of Foggia, Italy have published the research work: Advances in the preclinical characterization of the antimicrobial peptide AS-48, in the Journal: (JOURNAL)
• future: As part of its program in new antimicrobial research and development the WHO published a list of pathogens for which new antimicrobials are urgently needed (WHO 2017).

SUMMARY

This has led to a moment in which the number of multidrug-resistant (MDR) bacteria is alarmingly increasing (Laxminarayan et_al, 2013; McCullough et_al, 2016). A killing mechanism unrelated to pore formation . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.